BP000145-GD20: Recombinant Human Interleukin-2 (IL-2) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine CTLL-2 cells is less than 0.1 ng/ml, corresponding to a Specific Activity of 1.0 x 10^7 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000083-GD26: Recombinant Human IFNα 2b Pegylated
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^6 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000123-GD22: Recombinant Human Tumor Necrosis Factor alpha (TNFα) Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is less than 0.03 ng/ml. Specific Activity of 3.0 x 10^7 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000997-GD23: Recombinant Human Beta-Nerve Growth Factor (β-NGF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells was less than1.0 ng/ml. Corresponding to a specific activity of > 1 x 106 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000082-GD27: Recombinant Human IFN alpha 2a (IFNA2) Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000087-GD24: Recombinant Human Interferon-gamma (IFNγ) Protein
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be greater than 1.5 x 107 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000179-GD28: Recombinant Human Epidermal Growth Factor (EGF) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP003061: Recombinant Human ACE2-His-Avi Protein (rhACE2-His)
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003055: Biotinylated Recombinant SARS-CoV-2 Spike S1-His-Avi Protein (Spike Protein S1 Subunit)
Source: mammalian cells.
Activity: Immobilized biotinylated recombinant SARS-CoV-2 Spike S1-His-Avi protein at 1 ug/ml (100 ul/well). Dose response curve for the recombinant human ACE2-Fc fusion protein with the EC50 of 81 ng/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.C016: NovoSeven Biosimilar Stable Cell Line (CHO)
The yield of NovoSeven biosimilar from the CHO stable cell line was above 30 mg/L in a 1000 liter manufacturing.